Dynavax Technologies Corporation news

   Watch this stock
Showing stories 11 - 20 of about 89   

Articles published

DVAX 21.31 +1.59 (8.04%)
price chart
Dynavax Technologies Corporation Registers High Short Interest
Dynavax Technologies Corporation (NASDAQ:DVAX) is currently valued at $17.37 per share. The shares are trading 16.9% off their 52-week peak and 28% above their 52-week low.
Volume Movers: Tenneco Inc , Dynavax Technologies Corp , Piedmont Natural ...  Winston View
Dynavax Technologies Corporation (DVAX) news: Dynavax: An Update On This ...
Dynavax Technologies Corporation is a clinical-stage biopharmaceutical company that discovers and develops novel products to prevent and treat infectious and inflammatory diseases.
Dynavax Receives Milestone Payments from AstraZeneca  Zacks.com
Related articles »  
Interview with the CEO: Dynavax Technologies Corporation (DVAX)
Eddie Gray joined Dynavax Technologies Corporation as Chief Executive Officer and was appointed to the board in May 2013. Most recently, Mr. Gray served as the President of Pharmaceuticals Europe at GlaxoSmithKline plc (GSK) since 2008, and as ...
DynaVax Technologies: The Small Cap Gem Focus Stock Of The Week (DVAX)
Their technology looks to inhibit Toll-like Receptors (TLRs). TLRs are key receptors of the innate immune system that can induce strong inflammatory responses.
Share Price of Dynavax Technologies Corporation Drops by -0.85%
Dynavax Technologies Corporation (NASDAQ:DVAX) has dropped 0.85% during the past week, however, the bigger picture is still very bullish; the shares have posted positive gains of 2.92% in the last 4 weeks.
Dynavax Technologies Hits New 12-Month High at $21.93 (DVAX)
Dynavax Technologies logo Dynavax Technologies (NASDAQ:DVAX)'s share price hit a new 52-week high on Wednesday , American Banking & Market News reports.
Company Shares of Dynavax Technologies Corporation Drops by -5.61%
Dynavax Technologies Corporation (NASDAQ:DVAX) has lost 5.61% during the past week and dropped 8.87% in the past 4 weeks. The shares are however, marginally negative as compared to the S&P 500 for the past week with a loss of 8.39%.
Analysts Anticipate Dynavax Technologies to Announce ($1.07) Earnings Per ...  Dakota Financial News
Investors Are Gambling: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), PostRock ...  Property Mentor
Dynavax Technologies Corporation Short Interest Climbs by 18.8%
Dynavax Technologies Corporation (NASDAQ:DVAX) has shown a rise of 18.8% or 837,519 shares in the short positions. The bets have increased to 5,291,225 shares on January 30,2015 from 4,453,706 shares on January 15,2015.
5 Stock in Different Moves: MannKind Corp. (NASDAQ:MNKD), Groupon ...  Property Mentor
Dynavax Technologies (DVAX) Shares March Higher, Can It Continue?
As of late, it has definitely been a great time to be an investor in Dynavax Technologies Corporation (DVAX - Snapshot Report).
Dynavax Technologies Corporation Analyst Rating Update
Dynavax Technologies Corporation (NASDAQ:DVAX) has received a Neutral rating, according to the latest recommendation of 3 from research firm, Zacks.
Analysts Give Average Rating of "Strong Buy" to Dynavax ...  The Legacy